• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗高尿酸血症的尿酸转运蛋白1抑制剂类天然产物综述

A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia.

作者信息

Yuan Qianghua, Cheng Yuan, Sheng Rong, Yuan Yan, Hu Mei

机构信息

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China.

School of Medical and Life Sciences/Reproductive & Women-Children Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China.

出版信息

Evid Based Complement Alternat Med. 2022 Oct 28;2022:5419890. doi: 10.1155/2022/5419890. eCollection 2022.

DOI:10.1155/2022/5419890
PMID:36337587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9635963/
Abstract

Hyperuricemia is a common disease caused by a high level of uric acid. Urate transporter 1 (URAT1) is an important protein and mediates approximately 90% of uric acid reabsorption. Therefore, the URAT1 inhibitor is a class of uricosuric medicines widely used in the clinic for the treatment of hyperuricemia. To find the new medicine with stronger URAT1 inhibition and lower toxicity, researchers have been exploring natural products. This study systematically summarizes the natural products with URAT1 inhibition. The results show that many natural products are potential URAT1 inhibitors, such as flavonoids, terpenoids, alkaloids, coumarins, stilbenes, and steroids, among which flavonoids are the most promising source of URAT1 inhibitors. It is worth noting that most studies have focused on finding natural products with inhibition of URAT1 and have not explored their activities and mechanisms toward URAT1. By reviewing the few existing studies of the structure-activity relationship and analyzing common features of natural products with URAT1 inhibition, we speculate that the rigid ring structure and negative charge may be the keys for natural products to produce URAT1 inhibition. In conclusion, natural products are potential URAT1 inhibitors, and exploring the mechanism of action and structure-activity relationship will be an important research direction in the future.

摘要

高尿酸血症是一种由尿酸水平升高引起的常见疾病。尿酸盐转运蛋白1(URAT1)是一种重要的蛋白质,介导约90%的尿酸重吸收。因此,URAT1抑制剂是一类在临床上广泛用于治疗高尿酸血症的促尿酸排泄药物。为了找到具有更强URAT1抑制作用和更低毒性的新药,研究人员一直在探索天然产物。本研究系统总结了具有URAT1抑制作用的天然产物。结果表明,许多天然产物是潜在的URAT1抑制剂,如黄酮类、萜类、生物碱、香豆素、芪类和甾体类,其中黄酮类是最有前景的URAT1抑制剂来源。值得注意的是,大多数研究都集中在寻找具有URAT1抑制作用的天然产物,而没有探索它们对URAT1的活性和作用机制。通过回顾现有的少数结构-活性关系研究,并分析具有URAT1抑制作用的天然产物的共同特征,我们推测刚性环结构和负电荷可能是天然产物产生URAT1抑制作用的关键。总之,天然产物是潜在的URAT1抑制剂,探索其作用机制和结构-活性关系将是未来的一个重要研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/67ae0cdf206f/ECAM2022-5419890.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/7c101c5ed7e7/ECAM2022-5419890.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/5f1b4477a91f/ECAM2022-5419890.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/ad69c26fd16d/ECAM2022-5419890.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/0da698b26dc0/ECAM2022-5419890.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/05d6fccf1b27/ECAM2022-5419890.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/67ae0cdf206f/ECAM2022-5419890.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/7c101c5ed7e7/ECAM2022-5419890.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/5f1b4477a91f/ECAM2022-5419890.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/ad69c26fd16d/ECAM2022-5419890.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/0da698b26dc0/ECAM2022-5419890.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/05d6fccf1b27/ECAM2022-5419890.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3413/9635963/67ae0cdf206f/ECAM2022-5419890.006.jpg

相似文献

1
A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia.用于治疗高尿酸血症的尿酸转运蛋白1抑制剂类天然产物综述
Evid Based Complement Alternat Med. 2022 Oct 28;2022:5419890. doi: 10.1155/2022/5419890. eCollection 2022.
2
A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications.尿酸转运蛋白 1(URAT1)抑制剂治疗高尿酸血症和痛风的简要综述:现有治疗选择和潜在应用。
Eur J Pharmacol. 2021 Sep 15;907:174291. doi: 10.1016/j.ejphar.2021.174291. Epub 2021 Jul 1.
3
Virtual screening and biological evaluation of natural products as urate transporter 1 (URAT1) inhibitors.天然产物作为尿酸转运蛋白1(URAT1)抑制剂的虚拟筛选及生物学评价
J Biomol Struct Dyn. 2024 Mar 29:1-14. doi: 10.1080/07391102.2024.2331101.
4
Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.新型选择性URAT1抑制剂UR-1102的促尿酸排泄作用更强,使簇绒卷尾猴的血浆尿酸水平降低的程度比苯溴马隆更大。
J Pharmacol Exp Ther. 2016 Apr;357(1):157-66. doi: 10.1124/jpet.115.231647. Epub 2016 Feb 23.
5
Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.发现基于萘基三唑基甲烷的柔性硫代乙酸作为治疗痛风高尿酸血症的高活性尿酸转运蛋白1(URAT1)抑制剂。
Med Chem. 2017;13(3):260-281. doi: 10.2174/1573406412666160915163002.
6
Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).新型尿酸盐转运蛋白 1(URAT1)抑制剂:对近期专利文献(2016-2019 年)的综述。
Expert Opin Ther Pat. 2019 Nov;29(11):871-879. doi: 10.1080/13543776.2019.1676727. Epub 2019 Oct 14.
7
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves.鉴定膳食类黄酮对 URAT1(肾脏尿酸重吸收抑制剂)的抑制活性:基于南非路易波士茶的体外筛选和分级方法。
Nutrients. 2022 Jan 28;14(3):575. doi: 10.3390/nu14030575.
8
Molecular basis of the urate transporter URAT1 inhibition by gout drugs.痛风药物对尿酸转运蛋白URAT1的抑制作用的分子基础。
bioRxiv. 2024 Sep 12:2024.09.11.612563. doi: 10.1101/2024.09.11.612563.
9
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods.天然和合成尿酸转运蛋白1抑制剂的最新进展及新型筛选方法
Evid Based Complement Alternat Med. 2021 Oct 31;2021:5738900. doi: 10.1155/2021/5738900. eCollection 2021.
10
Potentiation of the Uricosuric Effect of Dotinurad by -Inhibition of the Uric Acid Reabsorptive Transporter 1.通过抑制尿酸重吸收转运蛋白1增强度替尿酸的促尿酸排泄作用。
Drug Metab Dispos. 2023 Nov;51(11):1527-1535. doi: 10.1124/dmd.123.001412. Epub 2023 Aug 29.

引用本文的文献

1
Screening and evaluation of purines-degrading lactic acid bacteria isolated from traditional fermented foods in Yunnan Province and their uric acid-lowering effects .从云南传统发酵食品中分离的嘌呤降解乳酸菌的筛选、评价及其降尿酸作用
Front Microbiol. 2025 Jul 18;16:1627956. doi: 10.3389/fmicb.2025.1627956. eCollection 2025.
2
Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions.石榴皮鞣花素通过恢复高尿酸血症诱导的肾脏和肠道功能障碍来减轻高尿酸血症。
J Adv Res. 2025 Mar;69:449-461. doi: 10.1016/j.jare.2024.03.029. Epub 2024 Apr 10.

本文引用的文献

1
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout.肠道微生物群重塑:应对高尿酸血症和痛风的有前途的治疗策略。
Front Cell Infect Microbiol. 2022 Aug 10;12:935723. doi: 10.3389/fcimb.2022.935723. eCollection 2022.
2
A glance into the future of gout.痛风的未来展望
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098. doi: 10.1177/1759720X221114098. eCollection 2022.
3
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves.
鉴定膳食类黄酮对 URAT1(肾脏尿酸重吸收抑制剂)的抑制活性:基于南非路易波士茶的体外筛选和分级方法。
Nutrients. 2022 Jan 28;14(3):575. doi: 10.3390/nu14030575.
4
Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trial.中药降尿酸方治疗高尿酸血症的疗效:一项双盲非劣效性随机对照临床试验研究方案。
Trials. 2022 Jan 3;23(1):1. doi: 10.1186/s13063-021-05959-2.
5
Role of diet in hyperuricemia and gout.饮食在高尿酸血症和痛风中的作用。
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101723. doi: 10.1016/j.berh.2021.101723. Epub 2021 Nov 19.
6
Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation.基于 3D 形状和对接的虚拟筛选方法和生物学评价鉴定新型天然尿酸盐转运蛋白 1 抑制剂。
Bioorg Chem. 2021 Dec;117:105444. doi: 10.1016/j.bioorg.2021.105444. Epub 2021 Nov 5.
7
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods.天然和合成尿酸转运蛋白1抑制剂的最新进展及新型筛选方法
Evid Based Complement Alternat Med. 2021 Oct 31;2021:5738900. doi: 10.1155/2021/5738900. eCollection 2021.
8
Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.小檗红碱通过调节尿酸转运体和 JAK2/STAT3 信号通路来减轻氧嗪酸钾和次黄嘌呤诱导的高尿酸血症。
Eur J Pharmacol. 2021 Dec 5;912:174592. doi: 10.1016/j.ejphar.2021.174592. Epub 2021 Oct 23.
9
Effects of sodium-glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂对 2 型糖尿病患者血尿酸的影响:系统评价和网络荟萃分析。
Diabetes Obes Metab. 2022 Feb;24(2):228-238. doi: 10.1111/dom.14570. Epub 2021 Nov 2.
10
Antihyperuricemic Effect of Green Alga Ulvan through Regulating Urate Transporters.绿藻岩藻聚糖通过调节尿酸转运蛋白发挥降尿酸作用。
J Agric Food Chem. 2021 Sep 29;69(38):11225-11235. doi: 10.1021/acs.jafc.1c03607. Epub 2021 Sep 22.